Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 29

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 29
---
 outstanding during
the six months ended June 30, 2025 or the six month period ended June 30, 2024.

NOTE
5 – PROPERTY AND EQUIPMENT

Property
and equipment, net, consisted of the following as of June 30, 2025 and December 31, 2024:

    June 30,  
    December 31, 

    2025  
    2024 

    (Successor)  
    (Successor) 
  
    Laboratory equipment 
    $2,507,839  
    $2,507,839 
  
    Computers 
     38,323  
     38,323 
  
    Furniture 
     8,429  
     8,429 
  
    Total cost 
     2,554,591  
     2,554,591 
  
    Less: accumulated depreciation 
     (2,171,785) 
     (2,026,070)
  
    Property and equipment,
    net 
    $382,806  
    $528,521 

Successor depreciation expense for the three months ended June 30,
2025 and 2024 was $76,294 and $114,304, and for the six months ended June 30, 2025 and for period from February 14, 2024 through June
30, 2024 Successor depreciation expense was $145,715 and $190,591, respectively. Predecessor depreciation expense for the period January
1, 2024 through February 13, 2024 was $37,356.

NOTE
6 – ACCRUED LIABILITIES

Accrued
liabilities consisted of the following as of June 30, 2025 and December 31, 2024:

    June 30,  
    December 31, 

    2025  
    2024 

    (Successor)  
    (Successor) 
  
    Employee-related liabilities 
    $5,850  
    $244,302 
  
    Accrued franchise taxes 
     78,448  
     78,448 
  
    Accrued legal expenses 
     -  
     593,825 
  
    Insurance payable 
     138,663  
     - 
  
    Penalty for late S-1 filing and effectiveness 
     55,000